Patents by Inventor Barredo Fuente

Barredo Fuente has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11117925
    Abstract: The present invention relates to new and improved processes for the preparation of deoxycholic acid (DCA) and pharmaceutically acceptable salts thereof, as well as to novel intermediates useful for the preparation of DCA and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: June 6, 2017
    Date of Patent: September 14, 2021
    Assignee: BIONICE, S.L.U.
    Inventors: Antonio Lorente Bonde-Larsen, Ignacio Herraiz Sierra, Yolanda Fernandez Sainz, Jose Luis Barredo Fuente, Alfonso Perez Encabo, Jose Angel Turiel Hernandez
  • Publication number: 20200262863
    Abstract: The present invention relates to new and improved processes for the preparation of deoxycholic acid (DCA) and pharmaceutically acceptable salts thereof, as well as to DCA and pharmaceutically acceptable salts thereof, the carbon atoms of which are derived partially or solely from plant sources.
    Type: Application
    Filed: October 24, 2018
    Publication date: August 20, 2020
    Inventors: Ignacio Herraiz Sierra, Alfonso Pérez Encabo, Antonio Lorente Bonde-Larsen, Francisco Javier Guerra Navarro, Yolanda Fernandez Sainz, José Luis Barredo Fuente, José Angel Turiel Hernandez
  • Publication number: 20180305395
    Abstract: The present invention relates to new and improved processes for the preparation of deoxycholic acid (DCA) and pharmaceutically acceptable salts thereof, as well as to novel intermediates useful for the preparation of DCA and pharmaceutically acceptable salts thereof.
    Type: Application
    Filed: June 6, 2017
    Publication date: October 25, 2018
    Inventors: Antonio LORENTE BONDE-LARSEN, Ignacio HERRAIZ SIERRA, Yolanda FERNANDEZ SAINZ, Jose Luis BARREDO FUENTE, Alfonso PEREZ ENCABO, Jose Angel TURIEL HERNANDEZ
  • Publication number: 20180086786
    Abstract: The present invention relates to new and improved processes for the preparation of deoxycholic acid (DCA) and pharmaceutically acceptable salts thereof, as well as to DCA and pharmaceutically acceptable salts thereof, the carbon atoms of which are derived solely from plant sources.
    Type: Application
    Filed: December 4, 2017
    Publication date: March 29, 2018
    Inventors: Antonio LORENTE BONDE-LARSEN, Ignacio HERRAIZ SIERRA, Yolanda FERNANDEZ SAINZ, Jose Luis BARREDO FUENTE, Alfonso PEREZ ENCABO, Jose Angel TURIEL HERNANDEZ, Francisco Javier GUERRA NAVARRO
  • Patent number: 7799540
    Abstract: The method of fermentation with selected strains of B. trispora described in the present invention makes it possible to achieve lycopene yields higher than those currently described. The methods of isolation, purification and formulation are applicable to any natural source of lycopene, especially to submerged cultures of mucoral fungi of the genera Blakeslea, Choanephora, Phycomyces or Mucor. The method of extraction makes it possible to simplify the recovery process and increase the purity of the product, relative to the methods previously described. The methods of formulation provide high added value, since they make it possible to obtain stabilized preparations of lycopene for direct application in the food and pharmaceutical fields.
    Type: Grant
    Filed: December 20, 2002
    Date of Patent: September 21, 2010
    Assignee: Vitatene, S.A.
    Inventors: Ana Teresa Marcos Rodríguez, Antonio Estrella De Castro, Javier Costa Perez, Manuel Antonio Oliver Ruiz, Nieves Fraile Yecora, Juan Luis De La Fuente Moreno, Marta Rodríguez Saiz, Bruno Diez Garcia, Enrieque Peiro Cezon, Angel Muñoz Ruiz, Walter Cabri, Juan Francisco Lopez Ortiz, José Luis Barredo Fuente
  • Patent number: 7252965
    Abstract: The invention consists of fermenting selected strains of Blakeslea trispora in conditions such that ?-carotene is produced in the form of stabilized preparations with residual contents of other carotenoids (?-carotene and ?-zeacarotene). The fermentation conditions chosen include the programmed addition of oxygen and/or ?-ionone during fermentation, and control of the age of the vegetative growth phases of the strains employed. The ?-carotene obtained can be used in the pharmaceutical and food sectors.
    Type: Grant
    Filed: January 23, 2003
    Date of Patent: August 7, 2007
    Assignee: Antibioticos, S.A.U.
    Inventors: Javier Costa Perez, Ana Teresa Marcos Rodríguez, Juan Luis De La Fuente Moreno, Marta Rodríguez Saiz, Bruno Diez Garcia, Enrique Peiro Cezon, Walter Cabri, José Luis Barredo Fuente
  • Publication number: 20050124031
    Abstract: Biosynthetic genes of ?-carotene from Blakeslea trispora that code for lycopene cyclase/phytoene synthase (carRP) and phytoene dehydrogenase (carB). The carRP gene, characterized by the DNA sequence SEQ ID NO:1, codes for the amino acid sequence SEQ ID NO:3, which has the lycopene cyclase/phytoene synthase enzymes. For its part, the carB gene, characterized by the DNA sequence SEQ ID NO:2, codes for the amino acid sequence SEQ ID NO:4, which possesses phytoene dehydrogenase enzyme activity. In addition, (i) procedures for constructing plasmids for the expression of additional copies of the aforesaid genes and (ii) methods for the expression of heterologous genes under the control of the promoters of said genes, are described.
    Type: Application
    Filed: September 26, 2002
    Publication date: June 9, 2005
    Applicant: VITATENE, S.A.
    Inventors: Marta Rodriguez Saiz, Ana Marcos Rodriguez, Bruno Diez Garcia, Juan Dela Fuente Moreno, Jose Barredo Fuente
  • Publication number: 20050124032
    Abstract: The present invention describes methods for (i) obtaining astaxanthin-overproducing strains of X. dendrorhous and (ii) the use of the aforementioned strains in improved conditions of fermentation. The methods used for selecting the strains are based on: (i) resistance to inhibitors of steroid synthesis, to inhibitors of respiration and to compounds that induce the formation of free radicals, (ii) color intensity of the colony and production of carotenoids on solid medium, (iii) production of astaxanthin in darkness, (iv) production of astaxanthin in conditions with a raised temperature and (v) production of astaxanthin with carbon sources other than glucose. These methods permit the efficient selection of mutants of X. dendrorhous with astaxanthin yields higher than the parent strain and little accumulation of other carotenoids. Cultivation of X. dendrorhous in liquid medium makes it possible to obtain a biomass that can be used directly in human and animal nutrition.
    Type: Application
    Filed: February 3, 2003
    Publication date: June 9, 2005
    Inventors: Juan De La Fuente Moreno, Enrique Peiro Cezon, Bruno Diez Garcia, Ana Marcos Rodriguez, Carmen Schleissner Sanchez, Marta Rodriguez Saiz, Carmelita Rodriguez Otero, Walter Cabri, Jose Barredo Fuente
  • Publication number: 20050106657
    Abstract: The method of fermentation with selected strains of B. trispora described in the present invention makes it possible to achieve lycopene yields higher than those currently described. The methods of isolation, purification and formulation are applicable to any natural source of lycopene, especially to submerged cultures of mucoral fungi of the genera Blakeslea, Choanephora, Phycomyces or Mucor. The method of extraction makes it possible to simplify the recovery process and increase the purity of the product, relative to the methods previously described. The methods of formulation provide high added value, since they make it possible to obtain stabilized preparations of lycopene for direct application in the food and pharmaceutical fields.
    Type: Application
    Filed: December 20, 2002
    Publication date: May 19, 2005
    Inventors: Ana Marcos Rodriguez, Antonio Estrella De Castro, Javier Costa Perez, Manuel Oliver Ruiz, Nieves Fraile Yecora, Juan De La Fuente Moreno, Marta Saiz, Bruno Diez Garcia, Enrieque Peiro Cezon, Angel Ruiz, Walter Cabri, Juan Lopez Ortiz, Jose Barredo Fuente
  • Patent number: 6815189
    Abstract: An isolated DNA sequence that encodes a peptide with CPC-acetylhydrolase enzymatic activity is disclosed. Also, a method of expressing CPC-acetylhydrolase activity that includes the steps of (a) providing a microorganism that is susceptible to transformation with the isolated DNA sequence and that, upon transformation, expresses the CPC-acetylhydrolase activity encoded by the sequence, and (b) transforming the microorganism with the DNA sequence to cause expression of the CPC-acetylhydrolase activity in the microorganism is disclosed. Also, a method for producing a microorganism with increased capacity to aid in the production of cephalosporin, which method includes the steps of (a) providing a microorganism that has CPC-AH activity by virtue of expression of the DNA sequence or of a fragment thereof coding for the CPC-acetylhydrolase enzyme activity; and (b) inactivating the activity by disrupting expression of the DNA sequence is disclosed.
    Type: Grant
    Filed: March 1, 2002
    Date of Patent: November 9, 2004
    Assignee: Antibiotics, S.A.U.
    Inventors: Javier Velasco Alvarez, Santiago Gutierrez Martin, Francisco Javier Casqueiro Blanco, Sonia Campoy Garcia, Francisco Fierro Fierro, Jose Luis Barredo Fuente, Bruno Diez Garcia, Juan Francisco Martin Martin
  • Publication number: 20040152154
    Abstract: Method of production of &bgr;-carotene by fermentation in mixed culture using (+) and (−) strains of Blakeslea trispora
    Type: Application
    Filed: January 21, 2004
    Publication date: August 5, 2004
    Inventors: Javier Costa Perez, Ana Teresa Marcos Rodriguez, Juan Luis De La Fuente Moreno, Marta Rodriguez Saiz, Bruno Diez Garcia, Enrique Peiro Cezon, Walter Cabri, Jose Luis Barredo Fuente
  • Patent number: 6635458
    Abstract: Enzymatic process for the preparation of cephalosporanic 7&bgr;-(4-carboxybutanamide) acid by using the modified enzyme D-aminoacid oxidase of Trigonopsis variabilis produced in Escherichia coli. The process for the expression of the enzyme comprises: (I) isolating the DNA corresponding to gene which codes for the enzyme D-aminoacid oxidase; (II) removing the intron which is contained in said gene; (III) inserting the DNA fragment obtained into the plasmide which is capable of replication in Escherichia coli; (IV) fusing at the extremity 5′ of the structural region of the gene a synthetic assembler which contains a nucleotide sequence which codes for six histidines; (V) transforming a strain of Escherichia coli with the resulting recombinant plasmide; (VI) cultivating the transformed cells of Escherichia coli; and (VII) recovering the enzyme D-aminoacid oxidase of the former cultivation operation through affinity chromatography.
    Type: Grant
    Filed: July 15, 1999
    Date of Patent: October 21, 2003
    Assignee: Antibioticos, S.A.U.
    Inventors: Jose Luis Garcia Lopez, Estrella Cortes Rubio, Jorge Alonso Palacios, Encarnacion Mellado Duran, Bruno Diez Garcia, Jose Manuel Guisan Seijas, Franciso Salto Maldonado, Barredo Fuente
  • Publication number: 20030119087
    Abstract: Enzymatic process for the preparation of cephalosporanic 7?-(4-carboxybutananude) acid by using the modified enzyme D-aminoacid oxidase of Trigonopsis variabilis produced in Escherichia coli. The process for the expression of the enzyme comprises: (I) isolating the DNA corresponding to gene which codes for the enzyme D-aminoacid oxidase; (II) removing the intron which is contained in said gene; (III) inserting the DNA fragment obtained into the plasmide which is capable of replication in Escherichia coli; (IV) fusing at the extremity 5′ of the structural region of the gene a synthetic assembler which contains a nucleotide sequence which codes for six histidines; (V) transforming a strain of Escherichia coli with the resulting recombinant plasmide; (VI) cultivating the transformed cells of Escherichia coli; and (VII) recovering the enzyme D-aminoacid oxidase of the former cultivation operation through affinity chromatography.
    Type: Application
    Filed: July 15, 1999
    Publication date: June 26, 2003
    Inventors: JOSE LUIS GARCIA LOPEZ, ESTRELLA CORTES RUBIO, JORGE ALONSO PALACIOS, ENCARNACION MELLADO DURAN, BRUNO DIEZ GARCIA, JOSE MANUEL GUISAN SEIJAS, FRANCISO SALTO MALDONADO, BARREDO FUENTE
  • Patent number: 6558921
    Abstract: An isolated DNA having the promoter sequence of the hex gene of P. chrysogenum or a DNA fragment that is hybridizable to the complement of the promoter sequence under stringent conditions and is capable of directing expression of DNA downstream of the fragment in P. chrysogenum. Also a process for promoting expression of a coding sequence of interest in a microorganism using the isolated DNA and a process to block expression of a gene of interest in a microorganism using the isolated DNA are disclosed.
    Type: Grant
    Filed: August 2, 2000
    Date of Patent: May 6, 2003
    Assignee: Antibioticos, S.A.
    Inventors: Jose Luis Barredo Fuente, Marta Rodriguez Saiz, Alfonso J. Collados de la Vieja, Migeul Angel Moreno Valle, Francisco Salto Maldonado, Bruno Diez Garcia
  • Patent number: 6300095
    Abstract: The invention relates to promoters of the genes glutamate dehydrogenase, &bgr;-acetylhexosaminidase and &ggr;-actin and their use in systems of expression, secretion and anti-sense of filamentary fungi. The invention also relates to the use of the promoters of the genes which code: (I) glutamate dehydrogenase NADP depending (EC.1.4.1.4) of Penicillium chrysogenum, (II) &ggr;-N-actylhexosaminidase (EC.3.2.1.52) of Penicillium chrysogenum and (III) &ggr;-actin of Penicillium chrysogenum and Acrimonium chrysogenum, which can be used for the construction of potent vectors of expression and secretion useful both for P. chrysogenum and for A. chrysogenum and related species. These promoters can also be used for blocking the genic expression through anti-sense construction. Under the control of the above mentioned promoters, it is possible to conduct the expression of other genes in filamentary fungi, thereby increasing the production of antibiotics and/or proteins inherent to the same.
    Type: Grant
    Filed: May 14, 1999
    Date of Patent: October 9, 2001
    Assignee: Antibioticos, S.A.
    Inventors: Jose Luis Barredo Fuente, Marta Rodriguez Saiz, Alfonso J. Collados De La Vieja, Migeul Angel Moreno Valle, Francisco Salto Maldonado, Bruno Diez Garcia
  • Patent number: 6251655
    Abstract: An isolated DNA encoding phenyl acetyl-CoA-ligase and a process of increasing the production of penicillin G in a strain of Penicillium chrysogenum by transforming the strain with the isolated DNA. Also vectors and host organisms having the isolated DNA.
    Type: Grant
    Filed: October 28, 1998
    Date of Patent: June 26, 2001
    Assignee: Antibioticos S.A.
    Inventors: Baltasar Minambres Rodriguez, Honorina Martinez Blanco, Elias Rodriguez Olivera, Belen Garcia Alonso, Jose Manuel Fernandez Canon, Jose Luis Barredo Fuente, Bruno Diez Garcia, Carmen Schleissner Sanchez, Miguel Angel Moreno Valle, Francisco Salto Maldonado, Jose Maria Luengo Rodriguez
  • Patent number: 6187574
    Abstract: Process for producing the enzyme D-amino acid oxydase of Rhodotorula gracilis in host cells. The process for the expression of the enzyme comprises isolating the complementary DNA corresponding to the messager RNA of the gene which codes for the D-amino acid oxydase of any strain of Rhodotorula gracillis producing said enzyme; fusing the fragment of DNA which codes for D-amino acid oxydase of Rhodotorula gracillis with a DNA sequence which contains a site of union to the ribosome and a high efficiency promoter sequence for the express of genes in host cells; inserting the DNA fragment into a plasmid appropriate for the host cell; cultivating the host cells transformed with said plasmid; and collecting the enzyme.
    Type: Grant
    Filed: April 28, 1998
    Date of Patent: February 13, 2001
    Assignee: Antibiotics, S.A.
    Inventors: Jose Luis Garcia Lopez, Estrella Cortes Rubio, Jorge Alonso Palacios, Jose Luis Barredo Fuente, Bruno Diez Garcia, Miguel Angel Moreno Valle, Carmen Schleissner Sanchez, Alfonso Collados de la Vieja, Alejandro Vitaller Alba, Francisco Salto Maldonado
  • Patent number: 6146871
    Abstract: A procedure for producing a modified 7.beta.-(4-carboxybutanamide) cephalosporinase enzyme which can be purified in a single chromatographic step. The procedure for production of the enzyme involves: mutagenizing the gene which codes for the enzyme from Acinetobacter sp. ATCC 53891 by inserting a nucleotide sequence coding for six histidine residues; fusing the mutant gene with high-efficiency promoter DNA sequences; transforming Escherichia coli cells with the fusion gene construct; growing the transformed Escherichia coli cells; and recovering the enzyme by the use of supports which contain metal chelates. 7-Aminocephalosporanic acid is an important intermediate for the manufacture of a wide range of antibacterial agents of the cephalosporin family.
    Type: Grant
    Filed: August 13, 1998
    Date of Patent: November 14, 2000
    Assignee: Sntibioticos, S. A.
    Inventors: Jose Luis Garcia Lopez, Estrella Cortes Rubio, Jose Manuel Guisan Seijas, Jose Luis Barredo Fuente, Bruno Diez Garcia, Alfonso Collados de la Vieja, Alejandro Vitaller Alba, Francisco Salto Maldonado